P3 Health Partners Inc.(PIII)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,267 of 2,960 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
PIII Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for P3 Health Partners Inc. (PIII), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PIII at 36.5/100 on a 32-signal composite quality model, placing it at rank #2,267 of 2,960 stocks — the bottom half of the AI-ranked universe. PIII scores in the top quartile across institutional flow (96.6). Areas of concern include earnings quality (5.0) and balance sheet strength (14.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), P3 Health Partners Inc. reports quarterly revenue of $386.4M, net income of $7.4M. Top institutional holders of PIII by reported 13-F value include HRT FINANCIAL, JANE STREET GROUP, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PIII trades on the Nasdaq exchange and files with the SEC under CIK 1832511. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PIII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for P3 Health Partners Inc. directly from SEC EDGAR. P3 Health Partners Inc.'s 13F Pro composite quality score has ranged between 33 and 47 since 2022, currently 36.5 — a declining long-term trajectory across 62 quarterly and live scoring snapshots.
Revenue
Q2 2026
$386.4M
Net Income
Q2 2026
$7.4M
D/E Ratio
Q2 2026
1.94
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-2.8% YoYNet Income
-8.9% YoYOperating Income
+15.7% YoYEPS (Diluted)
+16.3% YoYTotal Assets
-16.2% YoYTotal Debt
+48.5% YoYOp. Cash Flow
+17.2% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.46B -2.8% | $1.50B +18.5% | $1.27B +20.7% | $1.05B | — | $491.1M |
| Net Income | $-147.9M -8.9% | $-135.8M -135.1% | $-57.8M +78.6% | $-270.1M | — | $-31.4M |
| Operating Income | $-270.3M +15.7% | $-320.7M -90.9% | $-167.9M +89.2% | $-1.56B | — | $-28.6M |
| EPS (Diluted) | $-45.26 +16.3% | $-54.06 -8481.0% | $-0.63 +90.3% | $-6.50 | — | — |
| Total Assets | $656.6M -16.2% | $783.4M -9.0% | $861.0M -1.8% | $876.6M -62.9% | $2.36B +2121.2% | $106.4M |
| Total Debt | $273.4M +48.5% | $184.1M +69.9% | $108.3M +14.7% | $94.4M +12.8% | $83.7M +51.5% | $55.2M |
| Operating Cash Flow | $-91.2M +17.2% | $-110.1M -44.9% | $-76.0M +39.7% | $-126.0M | — | $-24.6M |
| Free Cash Flow | — | $-110.1M -41.5% | $-77.9M +39.3% | $-128.3M | — | $-27.5M |
Get alerted when PIII's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for P3 Health Partners Inc. including:
Top Institutional Holders of PIII
HRT FINANCIAL LP
$590.0K54,717 shJANE STREET GROUP, LLC
$588.5K54,495 shVANGUARD CAPITAL MANAGEMENT LLC
$448.0K41,484 shTrinity Financial Advisors LLC
$362.2K33,540 shMYDA Advisors LLC
$216.0K20,000 shCorient Private Wealth LLC
$213.2K19,737 shGEODE CAPITAL MANAGEMENT, LLC
$184.7K17,096 shScientech Research LLC
$176.2K16,318 shAbundance Wealth Counselors
$172.8K16,000 shRENAISSANCE TECHNOLOGIES LLC
$163.6K15,149 sh
| Fund | Value | Shares |
|---|---|---|
| HRT FINANCIAL LP | $590.0K | 54,717 |
| JANE STREET GROUP, LLC | $588.5K | 54,495 |
| VANGUARD CAPITAL MANAGEMENT LLC | $448.0K | 41,484 |
| Trinity Financial Advisors LLC | $362.2K | 33,540 |
| MYDA Advisors LLC | $216.0K | 20,000 |
| Corient Private Wealth LLC | $213.2K | 19,737 |
| GEODE CAPITAL MANAGEMENT, LLC | $184.7K | 17,096 |
| Scientech Research LLC | $176.2K | 16,318 |
| Abundance Wealth Counselors | $172.8K | 16,000 |
| RENAISSANCE TECHNOLOGIES LLC | $163.6K | 15,149 |
Companies Similar to PIII
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
agilon health, inc.
Telix Pharmaceuticals Ltd
FMC CORP
Pharming Group N.V.
Inventiva S.A.
Brookdale Senior Living Inc.
USANA HEALTH SCIENCES INC
OLIN Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put PIII on your watchlist
Track score changes the day P3 Health Partners Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PIII a good stock to buy?
13F Pro's AI-powered analysis of P3 Health Partners Inc. (PIII) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PIII are available on the PIII stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. PIII is classified as a small company.
Which hedge funds own PIII?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PIII. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of P3 Health Partners Inc.'s investment landscape.